Why Moderna Is the Biggest Winner From COVID Boosters So Far
Published
Some Americans could prefer Moderna's booster because of perceptions that it offers higher efficacy.
Full ArticlePublished
Some Americans could prefer Moderna's booster because of perceptions that it offers higher efficacy.
Full ArticleWatch VideoThe U.S. is expanding COVID-19 boosters, ruling that 16- and 17-year-olds can get a third dose of Pfizer's..